We are live on
!
Find out more
IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.89B
1-Year Est. Return
118.48%
This Fund
S&P 500
1 Year Est. Return
+118.48%
AUM
$1.89B
AUM Growth
-$83.2M
(-4.2%)
Holding
110
Top Buys
| 1 | +$38.4M | |
| 2 | +$30.3M | |
| 3 | +$29.5M | |
| 4 |
Boston Scientific
BSX
|
+$26M |
| 5 |
Merck
MRK
|
+$20.2M |
Top Sells
| 1 | +$64.8M | |
| 2 | +$37.9M | |
| 3 | +$31.2M | |
| 4 |
Penumbra
PEN
|
+$31.1M |
| 5 |
Teleflex
TFX
|
+$30.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
101
Penumbra
PEN
$12.6B
| – | – |
-100,000
|
|
||
102
RadNet
RDNT
$4.26B
| – | – |
-200,000
|
|
||
103
Sight Sciences
SGHT
$252M
| – | – |
-425,000
|
|
||
|
TERN
104
DELISTED
Terns Pharmaceuticals
TERN
| – | – |
-425,000
|
|
||
105
Teva Pharmaceuticals
TEVA
$38.7B
| – | – |
-1,000,000
|
|
||
|
106
Teleflex
TFX
$5.83B
| – | – |
-250,000
|
|
||
107
Tenet Healthcare
THC
$14B
| – | – |
-100,000
|
|
||
108
UnitedHealth
UNH
$369B
| – | – |
-50,000
|
|
||
|
UPB
109
Upstream Bio Inc
UPB
$351M
| – | – |
-750,000
|
|
||
110
Encompass Health
EHC
$10B
| – | – |
-100,000
|
|